Ítem
| 1 juny 2018 | |
| http://hdl.handle.net/2072/312276 | |
| Impact Journals | |
| Attribution 3.0 Spain | |
| http://creativecommons.org/licenses/by/3.0/es/ | |
|
Cèl·lules canceroses
Mama -- Càncer Breast -- Cancer Càncer -- Tractament Cancer -- Treatment |
|
| Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts | |
| info:eu-repo/semantics/article | |
| Recercat |
